These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31632062)

  • 21. Cross-talk between YAP and RAR-RXR Drives Expression of Stemness Genes to Promote 5-FU Resistance and Self-Renewal in Colorectal Cancer Cells.
    Bauzone M; Souidi M; Dessein AF; Wisztorski M; Vincent A; Gimeno JP; Monté D; Van Seuningen I; Gespach C; Huet G
    Mol Cancer Res; 2021 Apr; 19(4):612-622. PubMed ID: 33472949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
    Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
    Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
    [No Abstract]   [Full Text] [Related]  

  • 23. Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway.
    Kong Q; Li J; Zhao L; Shi P; Liu X; Bian C; Liu J; Liu T
    Virol J; 2021 Oct; 18(1):214. PubMed ID: 34717661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro].
    Li L; Dong L; Hui J; Gao F; Wang Q; Yang L; Zhang J; Yan J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Aug; 29(8):731-737. PubMed ID: 28795673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
    Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
    Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
    Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
    J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
    Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
    Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
    [No Abstract]   [Full Text] [Related]  

  • 29. Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis.
    Li Y; Hu Y; Yang L; Liu J; Cui C; Yang M; Zou D; Zhou L; Zhou Q; Ge W; Lang T
    Biomed Pharmacother; 2023 Apr; 160():114350. PubMed ID: 36804120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
    Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
    Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pressure loading regulates the stemness of liver cancer stem cells via YAP/BMF signaling axis.
    Ma D; Liang R; Luo Q; Song G
    J Cell Physiol; 2024 Oct; ():e31451. PubMed ID: 39358905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
    Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
    Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
    Li H; Gumbiner BM
    Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways.
    Wen Y; Ji Y; Zhang Y; Jiang B; Tang C; Wang Q; Chen X; Jia L; Gu W; Xu X
    Int J Med Sci; 2017; 14(12):1231-1240. PubMed ID: 29104479
    [No Abstract]   [Full Text] [Related]  

  • 37. WWC3 inhibits intimal proliferation following vascular injury via the Hippo signaling pathway.
    Chen B; Liu G
    Mol Med Rep; 2018 Apr; 17(4):5175-5183. PubMed ID: 29393412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.